|
|
 |
|
Viewing report
|
|
|
|
R&D Strategies: Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity
Datamonitor, Aug 2007, Pages: 144
Introduction
Waves of technological advancements have powered significant evolution in R&D from serendipitous drug discovery, through to rational drug design. However, as the low-hanging fruit has been picked, and recent technological advances have failed to yield high numbers of new therapies, the search is on to identify R&D strategies to improve R&D productivity
Scope
Overview of the pressures facing drug developers, including an analysis of whether the industry is facing an R&D productivity crisis In-depth analysis of R&D deal activity, together with a pipeline snapshot, to identify trends that are shaping the R&D environment Identification of strategy optimization recommendations designed to drive up R&D productivity Evaluation of case-studies of Big Pharma R&D strategies to determine how these companies are addressing the productivity problem
Highlights
Over the last decade, significant investment in novel technologies has failed to yield a substantial increase in innovative drugs To drive up future productivity, drug developers are making either incremental changes to fine-tune the R&D process or they are implementing paradigm changes to radically alter the way that R&D is carried out R&D productivity depends on accelerating and boosting the output of drug discovery and development, and there are a range of strategies to do this, including optimizing the R&D model and improving the R&D process
Reasons to Purchase
Gain a clear understanding of the factors driving drug developers to change R&D strategies Gain insight into the trends in R&D clinical pipeline deal activity and pipeline focus Understand how a wide of strategies can optimize R&D productivity and identify how these can best be implemented
Customers who bought this item also bought
Biomarkers: The Future of Next-Generation Drug R&D
New Approaches to Pharma R&D: Evolving Strategies to Rejuvenate R&D Efficiency
Bio/Pharma R&D Statistical Sourcebook 2008/2009
Companion Biomarkers in Drug Development
Addressing Pharma’s R&D Productivity Crisis: Technological and Strategic Initiatives to Improve Core Drug Discovery Capabilities
R&D Cost Cutting: Managing Cost Containment and Safeguarding Productivity
Innovative Drug R&D in China
Allergy Drug Pipeline and R&D 2009
Innovative Strategies and Models for R&D Success: The Evolving Networked Pharma Company
Drug Repositioning Strategies: Innovative Strategies to Boost Pipeline Productivity
Allergy Drug Pipeline and R&D 2009
Winning R&D Productivity Strategies: Exploiting innovation, licensing and outsourcing opportunities
|
|
|
|
